| 0.875 -0.022 (-2.47%) | 05-29 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.15 | 1-year : | 1.27 |
| Resists | First : | 0.99 | Second : | 1.09 |
| Pivot price | 0.92  |
|||
| Supports | First : | 0.82 | Second : | 0.69 |
| MAs | MA(5) : | 0.88 |
MA(20) : | 0.9 |
| MA(100) : | 1.31 |
MA(250) : | 1.43 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 12.6 |
D(3) : | 17.1 |
| RSI | RSI(14): 42.6 |
|||
| 52-week | High : | 4 | Low : | 0.54 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ BEAT ] has closed above bottom band by 26.0%. Bollinger Bands are 61.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 72 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.92 - 0.92 | 0.92 - 0.93 |
| Low: | 0.86 - 0.87 | 0.87 - 0.87 |
| Close: | 0.87 - 0.88 | 0.88 - 0.88 |
HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.
Wed, 27 May 2026
HeartBeam (BEAT) Upgraded to Buy: Here's What You Should Know - Yahoo! Finance Canada
Wed, 27 May 2026
BEAT Stock Price, Quote & Chart | HEARTBEAM INC (NASDAQ:BEAT) - ChartMill
Tue, 26 May 2026
HeartBeam (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection - The Globe and Mail
Thu, 14 May 2026
HeartBeam (BEAT) Advances Commercial Launch, Reports First-Quarter 2026 Results - Yahoo Finance
Mon, 11 May 2026
HeartBeam (BEAT) Launches Pilot Study for On-Demand 12-Lead ECG Patch in Coronary Artery Disease Patients - Yahoo Finance
Thu, 07 May 2026
HeartBeam (BEAT) Expands Concierge Cardiology Footprint With Atelier Health Agreement - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 56 (M) |
| Shares Float | 47 (M) |
| Held by Insiders | 15.3 (%) |
| Held by Institutions | 9.2 (%) |
| Shares Short | 2,910 (K) |
| Shares Short P.Month | 3,150 (K) |
| EPS | -0.57 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.05 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -195.2 % |
| Return on Equity (ttm) | -495.7 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.37 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -13 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -1.57 |
| PEG Ratio | 0 |
| Price to Book value | 14.58 |
| Price to Sales | 0 |
| Price to Cash Flow | -3.71 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|